3[3]Kohler T,Michea-Hamzehpour M,Epp SF,et al.Carbapenem activities against Pseudomonas aeruginosa:respective contributions of OprD and efflux systems[J].Antimicrob Agents Chemother,1999,43(2):424-427.
4[4]Bush K,Jacoby GA,Medeiros AA.A functional classification scheme for beta-lactamases and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995,39(6):1211-1233.
10[10]Arakawa Y,Shibata N,Shibayama K,et al.Convenient test for screening metallo-beta-lactamase-producing gramnegative bacteria by using thiol compounds[J].J Clin Microbiol,2000,38(1):40-43.
4Harris AD,Perencevich E,Roghmann MC,et al.Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients[J].Antimicrob Agents Chemother,2002,46:854-858.
5Coudron PE,Moland ES,Thomoson KS.Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veteranis medical center[J].J Clin Microbiol,2000;38:1791-1796.
6Marchandin H,Jean-Pierre H,De Champs C,et al.Production of a TEM-24 plasmid-mediated extended-spectrum beta-lactamase by a clinical isolate of Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,2000,44:213-216.
7Gales AC,Jone RN,Turnidge J,et al.Characterization of Pseudomonas aeruginosa isolates,occurrence rates,antimicrobial susceptibility patterns,and molecular typing in the global SENTRY Antimicrobial Surveillance Program,1997-1999[J].Clin Infect Dis,2001,32(Suppl 2):S146-155.
8Lister PD,Gardner VM,Sanders CC.Clavulanate induce expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin[J].Antimicrob Agents Chemother,1999,43:882-889.
